» Articles » PMID: 24142164

Quantification of Leishmania Infantum DNA in the Bone Marrow, Lymph Node and Spleen of Dogs

Abstract

The aim of the present study was to quantify the parasite load of Leishmania infantum in dogs using real-time PCR (qPCR). Bone marrow, lymph node and spleen samples were taken from 24 dogs serologically positive for L. infantum that had been put down by the official epidemiological surveillance service. According to the clinical signs the dogs were classified as asymptomatic or symptomatic. After DNA extraction, the samples were subjected to qPCR to detect and quantify L. infantum DNA. Out of the 24 dogs, 12.5% (3/24) were classified as asymptomatic and 87.5% (21/24) as symptomatic. Real-time PCR detected L. infantum DNA in all the animals, in at least one biological sample. In particular, 100% of bone marrow and lymph node scored positive, whereas in spleen, the presence of DNA was detected in 95.9% (23/24). In addition, out of 24 animals, 15 were microscopically positive to amastigote forms of L. infantum in bone marrow. No statistical significant difference was found in the overall mean quantity of DNA among the different biological samples (P = 0.518). Considering each organ separately, there was 100% positivity in bone marrow and lymph nodes, while among the spleen samples, 95.9% (23/24) were positive. Regarding the different clinical groups, the overall mean parasite load varied significantly (P = 0.022). According to the results obtained, it was not possible determine which biological sample was most suitable tissue for the diagnosis, based only on the parasite load. Therefore, other characteristics such as convenience and easily of obtaining samples should be taken into consideration.

Citing Articles

Clinical, histopathological and parasitological follow-up of dogs naturally infected by Leishmania infantum before and after miltefosine treatment and associated therapies.

Rosar A, Martins C, Menin A, Reck C, Grisard E, Wagner G PLoS One. 2025; 20(1):e0313167.

PMID: 39787198 PMC: 11717219. DOI: 10.1371/journal.pone.0313167.


A non-replicative antibiotic resistance-free DNA vaccine delivered by the intranasal route protects against canine leishmaniasis.

Alonso A, Alcolea P, Larraga J, Peris M, Esteban A, Cortes A Front Immunol. 2023; 14:1213193.

PMID: 37790927 PMC: 10543895. DOI: 10.3389/fimmu.2023.1213193.


Occurrence of in Wild Mammals Admitted to Recovery Centers in Spain.

Azami-Conesa I, Perez-Moreno P, Matas Mendez P, Sansano-Maestre J, Gonzalez F, Mateo Barrientos M Pathogens. 2023; 12(8).

PMID: 37624008 PMC: 10458632. DOI: 10.3390/pathogens12081048.


Tongue nodules in an atypical canine leishmaniasis in Brazil.

da Costa Neto J, Martins C, Marco K, Paz B, Monteiro G, de Melo R J Vet Med Sci. 2021; 83(10):1549-1553.

PMID: 34393149 PMC: 8569869. DOI: 10.1292/jvms.21-0131.


Culture-free genome-wide locus sequence typing (GLST) provides new perspectives on Trypanosoma cruzi dispersal and infection complexity.

Schwabl P, Maiguashca Sanchez J, Costales J, Ocana-Mayorga S, Segovia M, Carrasco H PLoS Genet. 2020; 16(12):e1009170.

PMID: 33326438 PMC: 7743988. DOI: 10.1371/journal.pgen.1009170.